- Home
- COCP vs AMS Comparison
COCP vs AMS Comparison
Compare COCP & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCP
- AMS
- Stock Information
- Founded
- COCP 2006
- AMS 1980
- Country
- COCP United States
- AMS United States
- Employees
- COCP N/A
- AMS N/A
- Industry
- COCP Biotechnology: Pharmaceutical Preparations
- AMS Medical Specialities
- Sector
- COCP Health Care
- AMS Health Care
- Exchange
- COCP Nasdaq
- AMS Nasdaq
- Market Cap
- COCP 15.4M
- AMS 17.2M
- IPO Year
- COCP N/A
- AMS N/A
- Fundamental
- Price
- COCP $1.22
- AMS $2.56
- Analyst Decision
- COCP Strong Buy
- AMS
- Analyst Count
- COCP 1
- AMS 0
- Target Price
- COCP $6.00
- AMS N/A
- AVG Volume (30 Days)
- COCP 4.6M
- AMS 99.6K
- Earning Date
- COCP 11-12-2025
- AMS 11-12-2025
- Dividend Yield
- COCP N/A
- AMS N/A
- EPS Growth
- COCP N/A
- AMS N/A
- EPS
- COCP N/A
- AMS N/A
- Revenue
- COCP N/A
- AMS $29,251,000.00
- Revenue This Year
- COCP N/A
- AMS $5.06
- Revenue Next Year
- COCP N/A
- AMS N/A
- P/E Ratio
- COCP N/A
- AMS N/A
- Revenue Growth
- COCP N/A
- AMS 26.61
- 52 Week Low
- COCP $1.12
- AMS $2.27
- 52 Week High
- COCP $3.26
- AMS $3.59
- Technical
- Relative Strength Index (RSI)
- COCP 37.81
- AMS 49.43
- Support Level
- COCP $1.17
- AMS $2.41
- Resistance Level
- COCP $1.31
- AMS $3.10
- Average True Range (ATR)
- COCP 0.09
- AMS 0.18
- MACD
- COCP -0.00
- AMS -0.01
- Stochastic Oscillator
- COCP 20.00
- AMS 21.83
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.